lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18 and 75 years old; 2. Planned minimally invasive unilateral lung resection surgery; 3. Preoperative lung function test shows that the measured FEV1 value is greater than or equal to 1.2L and greater than or equal to 60% of the expected value 4. Capable of using smart devices and filling out electronic questionnaires; 5. Clear consciousness, no reading, communication or cognitive impairment, and signed informed consent form.
Exclusion criteria
Exclusion criteria: 1. Smoking cessation time before surgery is less than 2 weeks; 2. Preoperative patient functional status score (ECOG score) is greater than 1 point; 3. Patients who have received preoperative neoadjuvant therapy; 4. Patients who have undergone chest surgery in the past; 5. There is evidence to suggest continuous use of systemic corticosteroids within one month prior to surgery; 6. At the beginning of the treatment study, any unresolved toxicity from previous treatments is greater than CTCAE grade 1; 7. Having a history of major illnesses in the past, including a history of other malignant tumors within 5 years, and a history of angina pectoris, myocardial infarction, and stroke within 6 months; 8. There is evidence to suggest the existence of serious or uncontrollable systemic diseases, including thyroid disease, uncontrolled hypertension, coagulation dysfunction, or active infections, such as hepatitis B, hepatitis C, and human immunodeficiency virus (HIV); 9. According to the researcher's judgment, there are other situations where the patient is not suitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary function trajectory; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction level;Adverse event incidence rate;quality of life;Symptom rating; | — |
Countries
China
Contacts
The First Affiliated Hospital of Zhejiang University School of Medicine